(Q52539991)

2 May 2018

title

Microparticle-containing oncotic solutions augment in-vitro clot disruption by ultrasound. (English)

1 reference

2 May 2018

author name string

Birnbaum Y

1

1 reference

2 May 2018

Iakobishvili Z

2

1 reference

2 May 2018

Porter A

3

1 reference

2 May 2018

Hasdai D

4

1 reference

2 May 2018

Atar S

5

1 reference

2 May 2018

Siegel RJ

6

1 reference

2 May 2018

Battler A

7

1 reference

2 May 2018

publication date

1 June 2000

1 reference

2 May 2018

published in

Thrombosis Research

1 reference

2 May 2018

volume

98

1 reference

2 May 2018

issue

6

1 reference

2 May 2018

page(s)

549-557

1 reference

2 May 2018

Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction). Participants in the National Registry of Myocardial Infarction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Selection of patients with acute myocardial infarction for thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Transcutaneous ultrasound augments lysis of arterial thrombi in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Enhancement of thrombolysis in vivo without skin and soft tissue damage by transcutaneous ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: an in vitro and in vivo study.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Contrast echocardiography: influence of ultrasonic machine settings, mixing conditions, and pressurization on pixel intensity and microsphere size of Albunex solutions in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Acoustic lability of albumin microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Experimental study of stability of a contrast agent in an ultrasound field

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Fluid resuscitation with Haemaccel vs. human albumin following coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline. 1. Outcome and duration of stay in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Hypervolemic hemodilution in acute ischemic stroke: the Multicenter Austrian Hemodilution Stroke Trial (MAHST)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Avoidance of Blood Transfusion in Coronary Artery Surgery: A Trial of Hydroxyethyl Starch

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Retracted: Volume therapy with hypertonic saline hydroxyethyl starch solution in cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Volume replacement with hydroxyethyl starch solution in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

[Changes in coagulation physiology and rheology after preoperative normovolemic hemodilution]

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Hydroxyethyl Starch versus Albumin for Colloid Infusion Following Cardiopulmonary Bypass in Patients Undergoing Myocardial Revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Influence of hydroxyethyl starch on coagulation in patients during the perioperative period

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Review of the effects of hydroxyethyl starch on the blood coagulation system

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Influence of intravascular molecular weight of hydroxyethyl starch on platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Differential effects of serial hemodilution with hydroxyethyl starch, albumin, and 0.9% saline on whole blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Hydroxyethyl starch impairs in vitro coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Effects of gelatin-based resuscitation fluids on platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Reduced quality of clot formation with gelatin-based plasma substitutes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900214-0

7 January 2021

10.1016/S0049-3848(00)00214-0

Identifiers

DOI

1 reference

2 May 2018

PubMed ID

10899354

1 reference

2 May 2018